Results 21 to 30 of about 711 (133)
Canadian Journal of Gastroenterology and Hepatology, Volume 2017, Issue 1, 2017., 2017 With improved survival outcomes after pediatric liver transplantation (LT), health‐related quality of life (HRQoL) is an important outcome metric. Understanding the elements contributing to HRQoL after LT in children would enable more targeted strategies towards optimizing best outcomes.
Mar Miserachs +4 more
wiley +1 more source
Noncirrhotic portal hypertension: Another cause of liver disease in HIV patients
Annals of Hepatology, 2009 Noncirrhotic portal hypertension (NCPH) represents a relatively infrequent group of conditions that causes portal hypertension in the absence of cirrhosis. An association between NCPH and patients infected with human immunodeficiency virus (HIV) has been
Manuel Mendizabal +4 more
doaj +1 more source
Design and Validation of an Augmented Reality System for Laparoscopic Surgery in a Real Environment
BioMed Research International, Volume 2013, Issue 1, 2013., 2013 Purpose. This work presents the protocol carried out in the development and validation of an augmented reality system which was installed in an operating theatre to help surgeons with trocar placement during laparoscopic surgery. The purpose of this validation is to demonstrate the improvements that this system can provide to the field of medicine ...
F. López-Mir +6 more
wiley +1 more source
Etiology and Management of Hemorrhagic Complications of Portal Hypertension in Children
International Journal of Hepatology, Volume 2012, Issue 1, 2012., 2012 Portal hypertension in children represents a particular diagnostic and management challenge for several reasons: (1) treatment outcomes should be evaluated in relationship with a long‐life expectancy, (2) pediatric patients with portal hypertension constitute an heterogeneous population, both in terms of individual characteristics and diversity of ...
Alejandro Costaguta +2 more
wiley +1 more source
Hepatitis Research and Treatment, Volume 2011, Issue 1, 2011., 2011 Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are the principal risk factor associated to end‐stage liver diseases in the world. A study was carried out on end‐stage liver disease cases admitted to an important hepatology unit in Medellin, the second largest city in Colombia.
Fabian Cortes-Mancera +9 more
wiley +1 more source
Resección hepática mayor laparoscópica: hepatectomía izquierda por quiste hidático
Cirugía del UruguaySe presenta el caso de una paciente de 45 años, procedente del medio rural en estudio por epigastralgia de larga data sin vínculo con las ingestas. Sin hallazgos a destacar al examen físico.
Gonzalo San Martín +6 more
doaj +1 more source
The Economics of Liver Fibrosis Diagnosis: Systematic Review of Non‐Invasive Test Cost‐Effectiveness
Liver International Communications, Volume 6, Issue 4, December 2025.ABSTRACT Hepatic diseases progress silently, leading to fibrosis, cirrhosis, and hepatocellular carcinoma. Although liver biopsy remains the gold standard for fibrosis assessment, it is limited by invasiveness and sampling variability. Non‐invasive liver tests (NILTs) can mitigate biopsy‐related risks.
Marilia Mastrocolla de Almeida Cardoso +7 more
wiley +1 more source
Aetiology, outcomes and prognostic indicators of paediatric acute liver failure
Anales de Pediatría (English Edition), 2018 Introduction: Acute liver failure (ALF) is a multisystem disease with severe impairment of liver function of acute onset. The Paediatric End-stage Liver Disease (PELD) score is used as a predictor of mortality in chronic liver disease, however experience
Juan José Gilbert Pérez +2 more
doaj +1 more source
Liver International, Volume 44, Issue 12, Page 3174-3182, December 2024.Abstract Background and Aims Metabolic dysfunction‐associated steatotic liver disease (MASLD) recurrence after liver transplantation (LT) seems unavoidable and gradual. We aimed to evaluate the diagnostic accuracy in the post‐LT setting of patients transplanted for metabolic dysfunction‐associated steatohepatitis (MASH) of recurrent hepatic steatosis ...
Laura Martínez‐Arenas +9 more
wiley +1 more source
Adenocarcinoma in Caroli′s Disease Treated by Liver Transplantation
HPB Surgery, Volume 7, Issue 1, Page 81-87, 1993., 1993 Caroli′s disease is characterized by congenital cystic dilatation of the intrahepatic bile ducts. In 7% of casea a malignant tumor develops complicating the course of the disease. We report the case of a 25 year‐old woman in whom Caroli′s disease was diagnosed at the age of 11. From that time on, she had several episodes of cholangitis.
J. Balsells +6 more
wiley +1 more source